Biosafety Aspects of Hybridoma Technology: Nature of Risks and Approaches to Their Management

Biosafety Aspects of Hybridoma Technology: Nature of Risks and Approaches to Their Management

This study investigates the biosafety aspects of hybridoma technology, focusing on the identification and management of associated risks. Monoclonal antibodies, essential tools in immunology, biotechnology, and medicine, are primarily produced through hybridoma technology. This process involves fus...

Full description

Saved in:
Bibliographic Details
Main Authors: Kateryna Shevchuk, Anastasia Baranovska, Andrii Chernetskyi, Nataliia Shchotkina, Alexander Besarab
Format: Article
Language:English
Published: Igor Sikorsky Kyiv Polytechnic Institute 2025-04-01
Series:Innovative Biosystems and Bioengineering
Subjects:
hybridoma technology
monoclonal antibodies
biosafety level
contamination risks
Online Access:https://ibb.kpi.ua/article/view/320712
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items